Home › Research › Tau biomarkers
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy
Du Pasquier RA, Jilek S, Kalubi M, Yerly S, Fux CA, Gutmann C, Cusini A, Günthard HF et al.. AIDS (London, England), 2013-01-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Objective To determine changes of cerebrospinal fluid (CSF) biomarkers of patients on monotherapy with lopinavir/ritonavir. Design The Monotherapy Switzerland/Thailand study (MOST) trial compared monotherapy with ritonavir-boosted lopinavir with continued therapy. The trial was prematurely stopped due to virological failure in six patients on monotherapy.
What this study adds
Evidence grade: Low
This is a trial. This study looked at cerebrospinal fluid markers, including the astrocytic marker S100B, in HIV-infected patients taking lopinavir/ritonavir monotherapy, a trial stopped early because of virological failure. It concerns HIV brain markers, not Alzheimer's disease, so it has no direct implications for treating, curing or preventing Alzheimer's.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Du Pasquier, R. A., Jilek, S., Kalubi, M., Yerly, S., Fux, C. A., Gutmann, C., et al. (2013). Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy. AIDS (London, England). https://doi.org/10.1097/qad.0b013e32835a9a4a
Vancouver
Du Pasquier RA, Jilek S, Kalubi M, Yerly S, Fux CA, Gutmann C, et al. Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy. AIDS (London, England). 2013. doi:10.1097/qad.0b013e32835a9a4a. PMID: 23032410.
BibTeX
@article{dupasquier2013-23032410,
author = {Du Pasquier, R. A. and Jilek, S. and Kalubi, M. and Yerly, S. and Fux, C. A. and Gutmann, C. and Cusini, A. and Günthard, H. F. and others},
title = {{Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy}},
journal = {AIDS (London, England)},
year = {2013},
doi = {10.1097/qad.0b013e32835a9a4a},
pmid = {23032410},
url = {https://doi.org/10.1097/qad.0b013e32835a9a4a}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Design The Monotherapy Switzerland/Thailand study (MOST) trial compared monotherapy with ritonavir-boosted lopinavir with continued therapy.
- The trial was prematurely stopped due to virological failure in six patients on monotherapy.
- It, thus, offers a unique opportunity to assess brain markers in the early stage of HIV virological escape.
- Methods : Sixty-five CSF samples (34 on continued therapy and 31 on monotherapy) from 49 HIV-positive patients enrolled in MOST.
Why it matters
This study looked at cerebrospinal fluid markers, including the astrocytic marker S100B, in HIV-infected patients taking lopinavir/ritonavir monotherapy, a trial stopped early because of virological failure. It concerns HIV brain markers, not Alzheimer's disease, so it has no direct implications for treating, curing or preventing Alzheimer's.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 52/100
Published in a peer-reviewed journal, and it is a randomized controlled trial. Scored zero for sample size and effect reported because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (AIDS (London, England)) |
| Journal's citation record | 3 / 4 | AIDS: journal h-index 267 (OpenAlex, 2026-10-29) |
| Study design | 11 / 12 | A randomized controlled trial (from PubMed type “Randomized Controlled Trial”) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2013 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (pubmed indexes it as a clinical or observational study) |
| Randomized / blinded | 1 / 2 | Randomized (as stated in the record) |
| Times cited | 3 / 7 | Cited 25 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.7 citations a year over 15 year(s) since 2013 |
| Impact for its field and year | 2 / 6 | Cited 1.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Pietro Luigi Vernazza: h-index 80 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Zurich: institution h-index 1,220 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 10 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 23032410) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 52 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.